OpenURL Connection Search

Select item for more details and to access through your institution.

Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients.
Published in:
2021
By:
- Xuqi Sun;
- Jie Mei;
- Wenping Lin;
- Ziliang Yang;
- Wei Peng;
- Jinbin Chen;
- Yaojun Zhang;
- Li Xu;
- Minshan Chen;
- Sun, Xuqi;
- Mei, Jie;
- Lin, Wenping;
- Yang, Ziliang;
- Peng, Wei;
- Chen, Jinbin;
- Zhang, Yaojun;
- Xu, Li;
- Chen, Minshan
Publication type:
journal article
Effect of prior cancer on survival of hepatocellular carcinoma: implications for clinical trial eligibility criteria.
Published in:
2021
By:
- Xuqi Sun;
- Lingling Li;
- Li Xu;
- Zhongguo Zhou;
- Jinbin Chen;
- Juncheng Wang;
- Yaojun Zhang;
- Dandan Hu;
- Minshan Chen;
- Sun, Xuqi;
- Li, Lingling;
- Xu, Li;
- Zhou, Zhongguo;
- Chen, Jinbin;
- Wang, Juncheng;
- Zhang, Yaojun;
- Hu, Dandan;
- Chen, Minshan
Publication type:
journal article
Follow-up schedule for initial recurrent hepatocellular carcinoma after ablation based on risk classification.
Published in:
2020
By:
- Sun, Xuqi;
- Li, Lingling;
- Lyu, Ning;
- Mu, Luwen;
- Lai, Jinfa;
- Zhao, Ming
Publication type:
journal article
Impact of treatment interval between neoadjuvant immunochemotherapy and surgery in lung squamous cell carcinoma.
Published in:
BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12333-3
By:
- Gu, Chen;
- Teng, Xiao;
- sun, Xuqi;
- Liu, Jiacong;
- Zhu, Ziyue;
- Zhang, Lichen;
- Wu, Zhigang;
- Zou, Rui;
- Pang, Jinghua;
- Lyu, Xiayi
Publication type:
Article
Tumor micronecrosis predicts poor prognosis of patients with hepatocellular carcinoma after liver transplantation.
Published in:
BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10550-w
By:
- Wang, Yangyang;
- Zhang, Wei;
- Ge, Hongbin;
- Han, Xu;
- Wu, Jiangchao;
- Sun, Xuqi;
- Sun, Ke;
- Cao, Wanyue;
- Huang, Chao;
- Li, Jingsong;
- Zhang, Qi;
- Liang, Tingbo
Publication type:
Article
A Pathologically Friendly Strategy for Determining the Organ‐specific Spatial Tumor Microenvironment Topology in Lung Adenocarcinoma Through the Integration of snRandom‐seq and Imaging Mass Cytometry.
Published in:
Advanced Science, 2024, v. 11, n. 26, p. 1, doi. 10.1002/advs.202308892
By:
- Sun, Xuqi;
- Teng, Xiao;
- Liu, Chuan;
- Tian, Weihong;
- Cheng, Jinlin;
- Hao, Shuqiang;
- Jin, Yuzhi;
- Hong, Libing;
- Zheng, Yongqiang;
- Dai, Xiaomeng;
- Wu, Linying;
- Liu, Lulu;
- Teng, Xiaodong;
- Shi, Yi;
- Zhao, Peng;
- Fang, Weijia;
- Shi, Yu;
- Bao, Xuanwen
Publication type:
Article
Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients.
Published in:
BMC Cancer, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12885-021-08428-w
By:
- Sun, Xuqi;
- Mei, Jie;
- Lin, Wenping;
- Yang, Ziliang;
- Peng, Wei;
- Chen, Jinbin;
- Zhang, Yaojun;
- Xu, Li;
- Chen, Minshan
Publication type:
Article
The Optimal Management for Sub-Centimeter Hepatocellular Carcinoma: Curative Treatments or Follow-Up?
Published in:
Medical Science Monitor, 2019, v. 25, p. 4941, doi. 10.12659/MSM.916451
By:
- Xuqi Sun;
- Yaojun Zhang;
- Ning Lyu;
- Xiaoxian Li;
- Minshan Chen;
- Ming Zhao
Publication type:
Article
Real-world efficiency of lenvatinib plus PD-1 blockades in advanced hepatocellular carcinoma: an exploration for expanded indications.
Published in:
2022
By:
- Sun, Xuqi;
- Zhang, Qi;
- Mei, Jie;
- Yang, Ziliang;
- Chen, Minshan;
- Liang, Tingbo
Publication type:
journal article

Found: 9